LEBOVITS CHAIM (See Remarks) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 5/23/2024ACC: 0001104659-24-064415
Officer· See Remarks
Since Jul 2018
+50K
Net shares
Net buyer
$30.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
$0.58
Trade value
$14.47K
% of position
2.3%
5/21/2024
1.10M→1.12M
Common Stock
Direct
Shares
+25K
Price / share
$0.64
Trade value
$16K
% of position
2.2%
5/22/2024
1.12M→1.15M
Total
Net shares
+50K
Net value
$30.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2024 | A · Award | +25K | $0.58 | $14.47K | 2.3% | 1.10M | 1.12M |
| Common Stock Direct | 5/22/2024 | A · Award | +25K | $0.64 | $16K | 2.2% | 1.12M | 1.15M |
| Total | +50K | $30.48K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2M
Total
2M indirect2M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2M | Indirect |
| Total | 2M | 2M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported